Literature DB >> 6111332

Assessment of anti-psychotic drugs.

A V Mackay.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6111332      PMCID: PMC1401620          DOI: 10.1111/j.1365-2125.1981.tb00526.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  61 in total

1.  Muscarinic cholinergic receptor binding: influence of pimozide and chlorpromazine metabolites.

Authors:  H I Yamamura; A A Manian; S H Snyder
Journal:  Life Sci       Date:  1976-04-01       Impact factor: 5.037

2.  A standardized psychiatric assessment scale for rating chronic psychotic patients.

Authors:  M Krawiecka; D Goldberg; M Vaughan
Journal:  Acta Psychiatr Scand       Date:  1977-04       Impact factor: 6.392

3.  Pharmacotherapeutic trials in tardive dyskinesia.

Authors:  A V Mackay; G P Sheppard
Journal:  Br J Psychiatry       Date:  1979-12       Impact factor: 9.319

4.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

5.  Finger tremor and extrapyramidal side effects of neuroleptic drugs.

Authors:  P Collins; I Lee; P Tyrer
Journal:  Br J Psychiatry       Date:  1979-05       Impact factor: 9.319

6.  Ethopropazine and benztropine in neuroleptic-induced parkinsonism.

Authors:  G Chouinard; L Annable; A Ross-Chouinard; M L Kropsky
Journal:  J Clin Psychiatry       Date:  1979-03       Impact factor: 4.384

7.  Bodily reactions to people and events in schizophrenics.

Authors:  N Tarrier; C Vaughn; M H Lader; J P Leff
Journal:  Arch Gen Psychiatry       Date:  1979-03

8.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17

9.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

10.  Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.

Authors:  L Rivera-Calimlim; H Nasrallah; J Strauss; L Lasagna
Journal:  Am J Psychiatry       Date:  1976-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.